Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
LUNG
#3421
Pulmonx Corporation Common Stock
1.5
8
+0.64%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.64%
Aylık değişim
-9.71%
6 aylık değişim
-15.05%
Yıllık değişim
-81.28%
Önceki kapanış
1.5
7
Open
1.5
8
Bid
Ask
Low
1.5
8
High
1.5
8
Hacim
26
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
LUNG
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
39.49 M
39.8 M
40.26 M
40.75 M
41.25 M
—
Valuation ratios
Enterprise value
301.28 M
236.49 M
233.57 M
67.18 M
27.4 M
564.65 M
Price to earnings ratio
-5.64
-4.72
-4.67
-1.81
-1.15
-12.35
Price to sales ratio
4.05
3.17
3.03
1.14
0.71
8.04
Price to cash flow ratio
9.65
8.43
8.07
3.31
2.03
21.84
Price to book ratio
0.76
3.09
0.74
0.31
0.22
4.37
Enterprise value to EBITDA ratio
-5.31
-4.18
-4.13
-1.21
-0.49
-10.01
Profitability ratios
Return on assets %
0.08
0.08
0.1
0.1
0.1
0.38
Return on equity %
0.15
0.15
0.19
0.22
0.23
0.79
Return on invested capital %
61.58
67.77
87.64
105.15
125.41
385.97
Gross margin %
73.7
74.02
72.51
72.11
74.65
293.29
Operating margin %
69.3
56.46
64.62
62.05
66.94
250.06
EBITDA margin %
-67.92
-55.34
-62.92
-60.04
-64.52
-242.82
Net margin %
69.38
55.44
64.11
63.59
64.91
248.05
Liquidity ratios
Quick ratio
6.77
4.88
4.29
4.63
4.15
17.96
Current ratio
7.7
5.58
4.97
5.35
4.86
20.75
Inventory turnover
0.32
0.36
0.37
0.4
0.34
1.47
Asset turnover
0.12
0.14
0.14
0.16
0.15
0.6
Solvency ratios
Debt to assets ratio
0.22
0.23
0.25
0.25
0.27
1
Debt to equity ratio
0.4
0.43
0.48
0.54
0.62
2.07
Long term debt to total assets ratio
0.22
0.21
0.19
0.25
0.27
0.92
Long term debt to total equity ratio
0.4
0.4
0.38
0.54
0.62
1.93
Per share metrics
Operating cash flow per share
0.18
0.17
0.33
0.1
0.2
0.8
EBIT per share
-0.36
-0.34
-0.36
-0.37
-0.35
-1.43
EBITDA per share
-0.35
-0.34
-0.35
-0.35
-0.34
-1.38
Total debt per share
0.95
0.95
0.93
0.92
0.91
3.71
Cash per share
1.61
1.81
1.87
1.87
1.87
7.42
Net current asset value per share
3.59
3.48
3.1
2.97
2.72
12.27
Tangible book value per share
2.33
2.13
1.89
1.65
1.41
7.08
Working capital per share
3.12
2.86
2.48
2.41
2.16
9.91
Book value per share
2.39
2.19
1.94
1.71
1.47
7.31
Haberler
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates
Pulmonx社CEO、LUNGの株式1.38万ドル相当を売却
スティフェル、3Q決算後にパルモンクスの株式評価を「買い」で再確認
Pulmonx stock rating reiterated at Buy by Stifel after 3Q results
【決算速報】パルモックス、売上高は予想を上回り、利益は予想を上回る結果に
Pulmonx earnings beat by $0.08, revenue topped estimates
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
Cisco, Flutter, Manulife and more set to report earnings Wednesday
American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates
セレスティカの株価が約8%上昇している理由;こちらはプレマーケットで動いている20銘柄
セレスティカの株価が約8%上昇している理由;こちらはプレマーケットで動いている20銘柄